Abbott to acquire Solvay for $6.6 Billion
Posted by: DrugsNews on: 01 Oct, 2009
- In: News
- Comments Off
Five months after Solvay’s CEO Werner Cautreels announced that the company was searching for a proper suitor, this Monday, Abbott announced that it had signed a deal to purchase Belgium-based drug manufacturer Solvay Pharmaceuticals for $6.6 billion in cash.
Ex-US Solvay pharmaceuticals will be adding to Abbott’s existing pharma division. Solvay is currently active in [...]
